Tumor necrosis factor-alpha and interleukin-6 selectively regulate neutrophil function in vitro

Area of Science:

• Immunology
• Sepsis Pathophysiology
• Cellular Biology

Background:

• Neutrophils are critical effector cells in the host response to sepsis.
• Tumor necrosis factor-alpha (TNF-alpha) and Interleukin-6 (IL-6) are key cytokine mediators in sepsis.
• The role of IL-6 in sepsis is less understood than TNF-alpha, though elevated levels correlate with mortality.

Purpose of the Study:

• To investigate the effects of IL-6, alone and in combination with TNF-alpha, on neutrophil functions.
• To assess the impact of IL-6 on CD18 adhesion receptor expression, phagocytosis, and superoxide anion generation by neutrophils.

Main Methods:

• Human neutrophils were isolated from volunteers.
• Neutrophils were incubated with varying concentrations of IL-6 (10-1000 ng/ml).
• Neutrophil phagocytosis, superoxide anion generation, and CD18 expression were measured, with and without TNF-alpha.

Main Results:

• High-dose IL-6 (1000 ng/ml) significantly increased neutrophil phagocytosis and superoxide anion generation.
• Lower IL-6 concentrations did not affect these neutrophil functions.
• IL-6 did not enhance CD18 adhesion receptor expression; however, combined IL-6 and TNF-alpha significantly increased phagocytosis and superoxide generation.

Conclusions:

• IL-6 significantly enhances key neutrophil functions, phagocytosis and superoxide generation, at high concentrations.
• IL-6, particularly in combination with TNF-alpha, plays a role in modulating neutrophil activity during sepsis.
• These findings contribute to understanding IL-6's role in the complex inflammatory response to sepsis.